Counselors in Morganfield, KY Accepting Medicare

4 Counselors found. Showing 1 - 4

Wendy Elizabeth Wilson, LPCC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 111 S Morgan St, Morganfield, KY 42437 Phone: 270-285-9023    Fax: 270-285-9037

Malorey Gray, LPCA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 111 S Morgan St, Morganfield, KY 42437 Phone: 270-285-9023    Fax: 270-285-9037

Cassie Tavares, LPCC, NCC Counselor - Professional Medicare: Medicare Enrolled Practice Location: 233 N Townsend St, Morganfield, KY 42437 Phone: 270-389-3240

Mrs. Jillian Michael Humphrey, BCBA Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 452 Goose Pond Rd, Morganfield, KY 42437 Phone: 270-285-2265

News Archive

HIV drug could delay drug resistance, making skin cancer treatment effective for longer time

An HIV drug could stop one of the early changes in skin cancer cells that leads to them becoming resistant to treatment, according to a Cancer Research UK-funded study published in Cancer Cell today

Study establishes critical roles for cancer-causing Myc gene in stem cell biology

Stem cells might be thought of as trunks in the tree of life. All multi-cellular organisms have them, and they can turn into a dazzling variety other cells-kidney, brain, heart or skin, for example. One class, pluripotent stem cells, has the capacity to turn into virtually any cell type in the body, making them a focal point in the development of cell therapies, the conquering of age-old diseases or even regrowing defective body parts.

Racial disparities in PSA screening

In one of the first examinations of PSA screening in younger men, a study published by researchers at Duke Medicine's Prostate Center finds that one-fifth of men under age 50 reported undergoing a prostate specific antigen (PSA) test to detect prostate cancer in the previous year, yet only one in three young black men reported ever having a PSA test in the previous year.

Teva Pharmaceutical Industries enters into definitive agreement to acquire Labrys

Teva Pharmaceutical Industries Ltd., and Labrys Biologics, Inc., a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, today announced that Teva has entered into a definitive agreement to acquire Labrys, broadening Teva's array of biotechnology assets and capabilities.

Study: RNA editing technique shows promise in treating rare, severe form of muscular dystrophy

An RNA editing technique called "exon skipping" has shown preliminary success in treating a rare and severe form of muscular dystrophy that currently has no treatment, based on a new study from Northwestern Medicine and the University of Chicago. Children with the disease lose significant muscle strength early in life.

Read more Medical News

› Verified 9 days ago